Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
This Month's Exclusive News 3 Blue-Chip Stocks Built for a Rotating MarketAuthored by Chris Markoch. Publication Date: 3/8/2026. 
Key Points - Sector rotation in 2026 is favoring defensive, value-oriented areas such as utilities, healthcare, and consumer staples over mega-cap technology.
- Duke Energy and Gilead Sciences combine defensive characteristics with identifiable growth catalysts and reliable dividends.
- Hershey has rallied sharply with consumer staples, but its valuation now looks stretched relative to its earnings profile.
- Special Report: Elon Musk's $1 Quadrillion AI IPO
Sector rotation occurs when investors shift money out of market sectors that look overbought and into ones that seem undervalued. In 2026, that has meant rotating away from mega-cap technology names and toward value stocks, particularly in defensive sectors such as energy and consumer staples. The key issue is overvaluation. Big tech has run hot for more than two years, fueled by the emergence of artificial intelligence (AI). Despite concerns about a repeat of the dot-com bubble, investors largely ignored the lofty valuations of many of these names. Silver Is Now a Growth AND Income Play For decades, silver paid nothing. That just changed. One tiny ETF is delivering 20% annualized distributions plus 68% share appreciation in just 5 months. Click here to learn more about this fund. But valuation often matters sooner or later. As expectations for a firmer economy increase, investors are seeking value elsewhere — including blue-chip defensive names like the stocks profiled below. Utilities Provide Stability in a Rotating Market Duke Energy (NYSE: DUK) is a logical beneficiary of sector rotation. Duke is a major utility provider in the Southeast and Midwest United States. Utilities stocks are among the most defensive, often viewed as value and income plays. Duke offers an attractive, secure dividend with a yield of about 3.2%, and the company has raised that payout for 20 consecutive years. The changing U.S. energy landscape also creates opportunities for future growth at DUK. The company follows an "all of the above" approach to generation, including nuclear, hydroelectric and natural gas. Natural gas in particular has helped fuel the stock's strong bounce in 2026. But it's Duke's stable residential utility revenue base, combined with projected growth in areas such as data centers, that makes DUK a target in this rotation. DUK is up nearly 12% in 2026 and sits within about 5% of its consensus price target of $136.87, which would push the stock above its 52-week high. At roughly 20.5x earnings, the shares trade at a slight premium to their historical average. Since reporting earnings in February, analysts have been raising price targets amid expectations for strong year-over-year revenue growth in the back half of the year — a catalyst that could prompt a bullish re-rating. Biotech Strength Gives Gilead Defensive Growth Some analysts see biotechnology names benefiting from the current sector rotation. Gilead Sciences (NASDAQ: GILD) offers defensive growth within healthcare stocks, a sector that has generally lagged the broader market. Gilead is a leading provider of HIV therapies, with key drugs protected by patents into the 2030s. Investors are also encouraged by a pipeline of more than 50 candidates. Beyond HIV, Gilead expects to launch anito-cel, a CAR-T therapy for multiple myeloma, in 2026 and may secure a label expansion for its breast cancer drug Trodelvy. GILD is up nearly 18% in 2026, which pushed the stock to a 52-week high. It has pulled back slightly since, likely reflecting profit-taking after the run-up and creating a potential buy-the-dip opportunity. Analysts have a consensus price target of $156.72, roughly an 8% upside; many have raised targets since the February earnings report, with the most bullish sitting near $170. Gilead also pays a reliable dividend, with a yield around 2.28%, and has increased its payout for 10 consecutive years. Consumer Staples Rally Lifts Hershey Stock The Hershey Company (NYSE: HSY) has been one of the biggest beneficiaries of the rotation into consumer staples stocks in 2026. HSY is up nearly 25% this year and has broken out of the bearish trend that began in 2023. That earlier weakness stemmed from higher cocoa prices that persisted through 2025, which will continue to weigh on earnings in 2026. Still, the market is forward-looking, and analysts expect strong earnings and revenue growth this year. HSY is trading above its consensus price target of $222.21, and analysts have been lifting targets since Hershey's February report. Goldman Sachs is the most bullish, with a $267 target. In that report, Hershey increased its dividend by 5.9%, extending its streak to 15 consecutive annual increases. The stock yields about 2.5%, with an annual payout per share of $5.81. Following the recent rally, HSY trades at more than 50x earnings — a valuation that likely prompted heavy institutional selling last quarter, but one that could also offer investors another chance to buy into this familiar consumer name. | 
